Mesothelioma Science News
San Pedro, CA - July 23, 2008
|
1.
|
Pemetrexed plus gemcitabine as first-line chemotherapy for patients
with peritoneal mesothelioma: final report of a phase II trial
Click here |
| |
|
| 2.
|
Prevalence and pattern of lymph node metastasis in malignant pleural
mesothelioma
Click here |
| |
|
| 3.
|
A phase II trial of tetrathiomolybdate after surgery for malignant
mesothelioma: final results
Click here |
| |
|
| 4.
|
Assessment of biomarkers in asbestos-exposed workers as indicators
of cancer risk
Click here |
| |
|
| 5.
|
Orally ingested chrysotile asbestos affects rat lungs and pleura
Click here |
| |
|
| 6.
|
Long-term mortality from pleural and peritoneal cancer after
exposure to asbestos: Possible role of asbestos clearance
Click here |
| |
|
| 7.
|
Evaluation of public and worker exposure due to naturally occurring
asbestos in gravel discovered during a road construction project
Click here |
| |
|
| 8.
|
mTOR Mediates Survival Signals in Malignant Mesothelioma Grown as
Tumor Fragment Spheroids
Click here |
| |
|
| 9.
|
Mammalian target of rapamycin contributes to the acquired apoptotic
resistance of human mesothelioma multicellular spheroids
Click here |
| |
|
|
10.
|
Targeted drug delivery to mesothelioma cells using functionally
selected internalizing human single-chain antibodies
Click here |
|
PATIENT PROFILES
